Defendant

Atlassian, Inc.

1 case as defendant.

Company profile

Atlassian Corporation is a publicly-traded software company founded in 2002 in Sydney, Australia. The company is now globally headquartered in Sydney with a U.S. headquarters in San Francisco. Atlassian trades on the NASDAQ stock exchange under the ticker symbol TEAM. For the fiscal year ending in 2025, Atlassian reported revenue of $5.22 billion. As of 2025, the company had approximately 13,800 employees.

Atlassian is an operating company that provides collaboration, development, and issue-tracking software for business customers. Its flagship products are Jira, a project and issue-tracking tool, and Confluence, a team collaboration and knowledge base platform. Other major product lines include Trello for visual project management, Bitbucket for code management and version control, and Jira Service Management for IT service management (ITSM) teams. The company's tools are widely used by software development teams for agile project management, but have also been adopted across other business functions.

Based on the provided data, Atlassian is an operating company defending itself in patent litigation. It has been a defendant in one tracked case and has not been a plaintiff. This posture is typical of a technology company being targeted by patent assertion entities. The single lawsuit on record was filed in the U.S. District Court for the Eastern District of Texas, a venue frequently favored by patent plaintiffs.

The one tracked case is Datacloud Technologies LLC v. Atlassian, Inc., filed in April 2026. The plaintiff, Datacloud Technologies LLC, is a non-practicing entity (NPE) associated with the monetization firm IP Investments Group. Datacloud has sued nearly 70 companies in a litigation campaign asserting patents, originally from Intellectual Ventures, that are broadly related to cloud computing, file management, and network communications. Unified Patents, an anti-NPE organization, also identifies Datacloud as an NPE and has challenged the validity of at least one of its patents.